Workshop 6 Modeling and Simulation to help …
Modelling and simulation to help define MABEL and Starting dose in FIH studies B Laurijssens, BEL Pharm Consulting. Steven W Martin, Pharmacometrics Group, Dept Clinical Pharmacology,
Download Workshop 6 Modeling and Simulation to help …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Thomas Sudhop, MD - AGAH
www.agah.eu1 What is required for first into man? The EU IMPD Thomas Sudhop, MD 2 Scope Structure and content of an IMPD What is required for first into man trial?
Workshop PAEDIATRIC INVESTIGATION PLAN - …
www.agah.euBirka Lehmann AGAH Workshop PAEDIATRIC INVESTIGATION PLAN How to Adapt Clinical Development to the Particularities of Paediatrics? 13. -14. 01. 2009
BE assessment of transdermal patches - AGAH
www.agah.eutesa Labtec GmbH CONFIDENTIAL Route of administration Transdermal patches – the basics Release liner = protective film Drug containing adhesive matrix
Related documents
Calculation of the Minimum Anticipated Biological …
www.ema.europa.euSlide 1 Jennifer Sims, PhD AstraZeneca Member of ABPI / BIA Early Stage Clinical Trials Taskforce Calculation of the Minimum Anticipated Biological Effect Level (MABEL)